Pharmafile Logo

Gower Publishing

- PMLiVE

Organon buys Forendo in $1bn deal

Forendo purchase bolsters Organon’s pipeline with candidates in endometriosis and polycystic ovarian syndrome

Four wins coveted position on government roster £500m government campaign roster partners announced

28 September 2021: Four Communications has been successful in gaining a coveted position on the main integrated UK government roster for the next four years – achieving the ability to...

Four Agency Worldwide

Accelerating Revenue Cycle Performance in the Healthcare Industry

Michael Duke, Principal Healthcare Consultant at Baker Tilly US, discusses the importance of data and analytics for internal audits, organizational risk reduction, workflow automation, and to drive value in healthcare....

Impetus Digital

Biogen Idec building

Biogen investigating death linked to Aduhelm

The death of a 75-year-old patient taking Biogen’s Aduhelm has raised yet more questions around the recently approved Alzheimer’s therapy

- PMLiVE

Valneva strikes European COVID-19 vaccine deal

The European Union intends to purchase up to 60 million doses of Valneva’s its inactivated COVID-19 vaccine VLA2001 by the end of 2023

Woman on mobile phone

How femtech is changing the future of women’s health

The femtech industry has the potential to be the next stage of evolution in the open access movement. Taking on the role of a public library, which allows a wider...

Thrive Agency

Revolutionising the Digital Content Delivery Model

Pharmaceutical industry processes don’t have to make the delivery of marketing campaigns slow and unmanageable, and thus ineffective. Changing working practices and really, truly thinking differently about how to deliver...

M3 (EU)

- PMLiVE

Fishawack Health welcomes expert-led dermatology initiative FIDE to its group

Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology

Avalere Health

- PMLiVE

Moderna clashes with US government over COVID-19 vaccine

A year-long wrangle with the US government over who invented a core component of the Moderna COVID-19 vaccine could have far-reaching implications

- PMLiVE

Pfizer snaps up Biohaven’s migraine drug for $1.24bn

Pfizer will sell the migraine drug outside the US and will also gain the rights to a second drug

Graphic showing person with megaphone and two speech bubbles

Opening up about patient engagement

Read the third blog of the series looking at key barriers to effective patient engagement in pharma

Cuttsy + Cuttsy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links